1. Home
  2. TOWN vs RCUS Comparison

TOWN vs RCUS Comparison

Compare TOWN & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TowneBank

TOWN

TowneBank

HOLD

Current Price

$35.64

Market Cap

3.3B

Sector

Finance

ML Signal

HOLD

Logo Arcus Biosciences Inc.

RCUS

Arcus Biosciences Inc.

HOLD

Current Price

$25.57

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TOWN
RCUS
Founded
1998
2015
Country
United States
United States
Employees
2976
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
2.8B
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
TOWN
RCUS
Price
$35.64
$25.57
Analyst Decision
Buy
Analyst Count
0
10
Target Price
N/A
$31.90
AVG Volume (30 Days)
360.2K
1.2M
Earning Date
04-22-2026
05-05-2026
Dividend Yield
3.09%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$247,000,000.00
Revenue This Year
$35.63
N/A
Revenue Next Year
$5.18
$45.62
P/E Ratio
$16.23
N/A
Revenue Growth
N/A
N/A
52 Week Low
$31.91
$7.06
52 Week High
$37.86
$28.72

Technical Indicators

Market Signals
Indicator
TOWN
RCUS
Relative Strength Index (RSI) 55.23 58.88
Support Level $34.61 $19.78
Resistance Level $37.22 $28.72
Average True Range (ATR) 0.87 1.64
MACD -0.05 0.09
Stochastic Oscillator 55.95 62.34

Price Performance

Historical Comparison
TOWN
RCUS

About TOWN TowneBank

Towne Bank is a financial services company serving individuals, commercial enterprises and professionals, offering retail and commercial banking services in Virginia and North Carolina. The company has four reportable segments: Banking, which provides loan and deposit services, commercial mortgage brokerage, and investment and asset management services; Mortgage, which originates mortgage loans principally sold in the secondary market through purchase commitments from investors; Resort Vacation Management, which provides residential resort property management services; and Insurance, which provides property, casualty, life and health insurance solutions for businesses, individuals and community organizations through a variety of carriers.

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

Share on Social Networks: